Alexander E. Barkas

This profile gathers the share dealings of Alexander E. Barkas across 4 companies, led by Geron Corp, Complete Genomics Inc and Amicus Therapeutics, Inc. In total, 46 filings cover trades dated from 28 April 2006 to 20 May 2011.

In open-market terms, that means 1 purchase worth €2.2M on one side and 2 sales worth €71k on the other. Taken together, the purchases exceed the sales by €2.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 32 share grants and 2 option exercises.

The latest filing, published on 24 May 2011, reports a share grant in Geron Corp. The last purchase on record was published on 16 November 2010, which is 5,820 days ago. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.